XML 67 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCK-BASED COMPENSATION PLANS (Tables)
12 Months Ended
Dec. 31, 2021
STOCK-BASED COMPENSATION PLANS  
Summary of stock-based compensation expense

Year Ended December 31, 

    

2021

    

2020

    

2019

(dollars in thousands)

Restricted stock units

$

579

$

351

$

Performance restricted stock units

185

Total awards classified as equity

764

351

Stock appreciation rights

226

(137)

343

Total stock-based compensation expense

$

990

$

214

$

343

Schedule of the summary of outstanding restricted stock units

    

Weighted

Average

Restricted

Grant Date

Stock Units

Fair Value

Balance, December 31, 2018

$

Granted

Vested

Forfeited

Balance, December 31, 2019

$

Granted

73,700

18.98

Vested

Forfeited

(2,700)

19.03

Balance, December 31, 2020

71,000

$

18.98

Granted

59,994

15.81

Vested

(20,225)

18.86

Forfeited

(1,525)

18.11

Balance, December 31, 2021

109,244

$

17.27

Schedule of the summary of performance outstanding restricted stock units

Weighted

Performance

Average

Restricted

Grant Date

Stock Units

Fair Value

Balance, December 31, 2018

$

Granted

Vested

Forfeited

Balance, December 31, 2019

$

Granted

Vested

Forfeited

Balance, December 31, 2020

$

Granted

38,344

15.72

Vested

Forfeited

Balance, December 31, 2021

38,344

$

15.72

Schedule of the status of stock appreciation rights and changes

    

    

Weighted

Stock

Average

Appreciation

Grant Date

Rights

Assigned Value

Balance, December 31, 2018

91,800

$

5.73

Granted

110,160

16.32

Exercised

(91,800)

5.73

Expired

Forfeited

Balance, December 31, 2019

110,160

$

16.32

Granted

Exercised

Expired

Forfeited

(4,590)

16.32

Balance, December 31, 2020

105,570

$

16.32

Granted

Exercised

(6,120)

16.32

Expired

(1,530)

16.32

Forfeited

Balance, December 31, 2021

97,920

$

16.32

A further summary of outstanding stock appreciation rights as of December 31, 2021, is as follows:

Weighted Average

Stock Appreciation Rights

Remaining

Grant Date Assigned Values

    

Outstanding

    

Exercisable

    

Contractual Term

$ 16.32

97,920

85,680

7.2

years

Schedule of assumptions used in valuing stock appreciation rights

    

December 31, 2021

    

December 31, 2020

Risk-free interest rate

1.40

%

0.80

%

Expected volatility

35.52

%

34.72

%

Expected life (in years)

7.7

8.7

Expected dividend yield

3.20

%

3.96

%